Neumora Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.44M.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$4.02M, a 339.43% decline year-over-year.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $3.98M, a 116.89% increase year-over-year.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $4.87M, a 35.79% decline year-over-year.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $4.20M, a 42.03% decline from fiscal 2024.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $7.24M, a 11.56% increase from fiscal 2023.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $6.49M.
- Neumora Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$1.62M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$5.46M 10-Q · filed 2026-08-14 | -$1.48M derived: sum of 3 quarters · filed 2026-08-14 | $3.39M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$4.02M 10-Q · filed 2026-05-07 | -$40.00K derived: sum of 2 quarters · filed 2026-05-07 | $4.83M derived: sum of 3 quarters · filed 2026-05-07 | -$1.50M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $8.85M derived: sum of 2 quarters · filed 2026-03-30 | $2.52M derived: sum of 3 quarters · filed 2026-08-14 | $4.20M 10-K · filed 2026-03-30 |
| 2025-09-30 | $4.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.46M derived: sum of 2 quarters · filed 2026-08-14 | $215.00K 10-Q · filed 2025-11-06 | $2.05M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$6.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.65M 10-Q · filed 2026-08-14 | -$2.81M derived: sum of 3 quarters · filed 2026-08-14 | $4.76M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.68M 10-Q · filed 2026-05-07 | $3.51M derived: sum of 2 quarters · filed 2026-05-07 | $11.09M derived: sum of 3 quarters · filed 2026-05-07 | $13.03M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $9.41M derived: sum of 2 quarters · filed 2026-03-30 | $11.35M derived: sum of 3 quarters · filed 2026-03-30 | $7.24M 10-K · filed 2026-03-30 |
| 2024-09-30 | $7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.51M derived: sum of 2 quarters · filed 2025-11-06 | $5.40M 10-Q · filed 2025-11-06 | $3.24M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.18M 10-Q · filed 2025-08-06 | -$4.34M derived: sum of 3 quarters · filed 2025-08-06 | $1.92M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$4.11M 10-Q · filed 2025-05-12 | -$6.27M derived: sum of 2 quarters · filed 2025-05-12 | -$13.00K derived: sum of 3 quarters · filed 2025-05-12 | $3.11M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $4.10M derived: sum of 2 quarters · filed 2025-03-03 | $7.22M derived: sum of 3 quarters · filed 2025-03-03 | $6.49M 10-K · filed 2025-03-03 |
| 2023-09-30 | $6.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.38M derived: sum of 2 quarters · filed 2024-11-12 | $8.65M 10-Q · filed 2024-11-12 | $15.68M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.39M 10-Q · filed 2024-08-06 | $9.42M derived: sum of 3 quarters · filed 2025-03-03 | |
| 2023-03-31 | -$736.00K 10-Q · filed 2024-05-07 | $6.29M derived: sum of 2 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.62M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | -$8.65M 10-Q · filed 2023-11-01 |